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Highlights 
 There is an acute increase of serum NFL following both cranial irradiation and anesthesia 
in mice.  
 The levels of serum NFL do not correlate with the acute opening of the BBB in a mouse 
model of cranial irradiation.  
 Human data show that the levels of NFL in blood mirror the levels in CSF independently 
of the degree of BBB integrity.  
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Abstract 
A blood biomarker to monitor individual susceptibility to neuronal injury from cranial 
radiotherapy could potentially help to individualize treatment plans using radiation and thereby 
reduce the incidence and severity of late effects. An important aspect of such a blood biomarker is 
that its concentration is not confounded by varying degrees of release of the marker from the brain 
into the blood across the blood-brain barrier (BBB). In this study, we investigated serum 
neurofilament light (NFL) concentrations in 21-day old mice following a single dose of cranial 
irradiation (8 Gy). Cranial irradiation resulted in acute cell injury measured as a 12.9-fold increase 
in caspase activity 6 hours after irradiation, inflammation, measured as XXX and increased BBB 
permeability, measured as XXX. Serum levels of NFL peaked at 6 hours after both anesthesia and 
cranial irradiation but there was no correlation of serum NFL concentration with BBB permeability 
over time. Further, three groups of patients with different degrees of BBB impairment (measured 
as the CSF/serum albumin ratio) were investigated. There was no correlation of serum NFL 
concentration with CSF/serum albumin ratio (r=X, p=Y) but a strong correlation of serum NFL 
concentration with NFL concentration in CSF (r=X, p=Y). In conclusion, serum NFL appears to 
be a reliable blood biomarker for neuronal injury, which is not influenced by BBB permeability.  
Keywords 
Biomarker, late effects, cranial radiotherapy, neurotoxicity juvenile brain 
Abbreviations  
CNS; central nervous system, CSF; cerebrospinal fluid, NFL; neurofilament light protein, CIR; 
cranial irradiation, BBB; blood-brain barrier, BCB; blood-CSF barrier, CCL2; chemokine (C-C 
motif) ligand 2, ICAM-1; intercellular adhesion molecule 1, E-selectin; Endothelial-selectin  
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1. Introduction 
The need to find reliable acute biomarkers in blood that reflects neuronal injury is of high interest 
in the clinical setting. To be able to make an early and accurate diagnosis it is important to know 
how the biomarker behaves and what factors that could influence the levels of brain specific 
biomarker, such as the function of the blood brain barrier (BBB). One group of patients that would 
benefit greatly from an acute biomarker to determine individual susceptibility to central nervous 
system (CNS) injury is pediatric patients with tumors located in the CNS. The most common forms 
of solid tumors in children are located in the CNS, with an annual incidence of 4.2/100,000 in 
children in Sweden (Lannering et al., 2009), and  similar numbers in the U.S. (Ostrom et al., 2014). 
Tumor histology highly influences the survival rates; for example the five-year survival rate is 
94.1% for pilocytic astrocytoma but only 5.0% for glioblastoma (Ostrom et al., 2014). However, 
independent on the difference in survival rates, survivors are often living with severe and 
debilitating consequences of the treatment that they received when they were children, the so-
called “late effects”. For example, treatment of brain tumors significantly decreases the likelihood 
of being employed, getting married or having close friends (Gurney et al., 2009). Although all the 
treatment modalities (surgery, chemotherapy, and radiotherapy) cause negative complications, 
radiotherapy has the highest severity of late effects (Han et al., 2009). Cognitive impairment is one 
of the most severe complications after cranial radiotherapy for both children and adults (Duffner, 
2004; Duffner, 2010; Makale et al., 2017; Mulhern et al., 2004). Radiotherapy, the volume of brain 
tissue treated, young age at diagnosis and female gender are some risk factors for late effects 
(Fouladi et al., 2005; Han et al., 2009; Lahteenmaki et al., 2007). The precautions taken are not 
enough to prevent late effects and as of today, there is no way to determine individual susceptibility 
to cranial radiotherapy. The primary goal of modern treatment strategies is to improve the chance 
of survival and secondly improve the patients’ future quality of life. With the increasing number 
of survivors as a result of improved treatment strategies, it is important to also consider their future 
health and individual susceptibility when designing the treatment plan.  
An acute biomarker to determine individual susceptibility to CNS injury from cranial radiotherapy 
could potentially help to individualize treatment plans and reduce the incidence of late effects. Our 
results from preclinical irradiation models have demonstrated that inflammatory mediators such 
as the chemokine (C-C motif) ligand 2 (CCL2) could be correlated with the injuries seen on stem 
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cells in the hippocampus after cranial irradiation (CIR) to mice (Roughton et al., 2013). In the 
clinical setting, we have seen that the neuronal injury marker neurofilament light protein (NFL) 
increased by 120% in cerebrospinal fluid (CSF) three months after prophylactic radiotherapy to 
the brain of small cell lung cancer patients (Kalm et al., 2014). However, since lumbar puncture 
often necessitates anesthesia for children, blood-based analyses are a more suitable and useful 
alternative for clinical monitoring. We have recently developed an ultra-sensitive assay for NFL 
in plasma and serum (Gisslen et al., 2016). Using this assay we have shown that plasma/serum 
NFL concentrations increased in HIV-associated dementia (Gisslen et al., 2016), frontotemporal 
dementia (Rohrer et al., 2016) and Alzheimer’s disease (Mattsson et al., 2017), and correlate with 
longitudinal changes in brain volumes and cognitive functioning (Rohrer et al., 2016). Further, 
serum NFL concentration increases acutely and stays elevated for months following both severe 
and mild traumatic brain injury with correlations to both injury severity, as well as imaging 
measures of neuroaxonal injury and outcome (Ljungqvist et al., 2016; Shahim et al., 2016). Due 
to all of these previous studies, we consider NFL as a promising blood biomarker for neuronal 
injury following CIR. An important aspect of such a biomarker, however, is that its concentration 
is not confounded by blood-brain barrier (BBB) permeability. 
In the current study, we examine the correlation of serum NFL concentrations with markers of 
neuronal injury, inflammation and BBB integrity in mice following CIR. We also assess the 
potential influence of BBB permeability on serum NFL concentrations in patients with varying 
degrees of BBB impairment.  
1. Results 
1.1 CIR-induced injury response and cross-talk between the BBB and the immune system in 
mice 
To evaluate CIR-induced injury, we assessed a cell death parameter, inflammation markers and 
BBB permeability. First, cell death was investigated by a caspase activity assay (DevDase). We 
observed a 12.9-fold increase of caspase activity in brain tissue, indicative of apoptosis, 6 hours 
after CIR compared to untreated control mice (Fig. 1A, P<0.001). Further, at the 12-hour time-
point after CIR, there was still a significant increase of caspase activity compared to the control 
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levels (P=0.005). However, at this time-point, the increase was only 2.7-fold and at the 24-hour 
time-point, caspase activity had normalized.  
The inflammatory response was measured by CCL2 expression and was significantly increased by 
130% at 6 hours after CIR compared to control mice (Fig. 1B, P<0.001). Compared to the cell 
death analysis, the levels of CCL2 continued to increase and reached the peak at 12-hour and 24-
hour post CIR, when the levels of CCL2 had increased with 194% and 190%, respectively, 
compared to the control group (P<0.001). Not until 48 hours after CIR did the levels drop down 
to 50% above the controls (P=0.002), and one day further the levels were no longer different from 
the controls (Fig. 1B).  
 
Figure 1. The levels of caspase 3/7 activity (A), CCL2 (B), ICAM-1 (C) and E-selectin (D) were 
measured in brain homogenates at different time-points after CIR to the young mouse brain (P21). 
Data shown as mean ± SEM. N=8Controls, 6CIR. P<0.01**, P<0.001***. Only statistical differences 
between the control and the CIR groups are shown in the histogram.  
We also investigated classical markers for BBB and immune system cross-talk after CIR (Fig. 1C-
D). Intercellular adhesion molecule 1 (ICAM-1) expression was increased with 30.1% at the first 
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time-point, 6 hours, compared to the control group (Fig. 1C, P<0.001). This increase stayed more 
or less unchanged at the 12-hour time-point (29.1%, P<0.001). 24 hours after CIR the levels were 
only 17% higher than the controls (n.s. P=0.14). The levels of ICAM-1 however stayed on that 
level for the duration of the experiment (48-hours post-CIR, n.s. P=0.077 and 72-hours post-CIR, 
n.s. p=0.085). E-selectin, a protein involved in the rolling of leukocytes along the endothelial, was 
increased by 29.9% at 6 hours after CIR, however this was not significant compared to controls 
due to a high standard error within the groups (Fig. 1D). The data however indicate that there is a 
recruitment of immune cells to the brain acutely after CIR since the 6-hour time-point had 49.3% 
higher E-selectin expression compared to the 24-hour time-point (P=0.008). 
2.2 CIR-induced BBB permeability in mice 
We measured 14C-sucrose brain and CSF uptake ratios to assess blood–CSF and BBB permeability 
after CIR with ratios corrected for residual blood volume. Radiation resulted in an opening of the 
BBB with 103% at 24 hours after CIR compared to controls in the entire brain (Fig. 2A, P<0.001). 
The accumulation of 14C-sucrose was increased by 103% in the cortex (Fig. 2B, P<0.001), 108% 
in the striatum/thalamus (Fig. 2C, P=0.0013), 87.8% in the brain stem (Fig. 2D, P<0.001), 106% 
in the hippocampus (Fig. 2E, P=0.001), and 105% the cerebellum (Fig. 2F, P<0.001). In addition, 
the levels of 14C-sucrose in the CSF showed an increase of 39.1% at the 24-hour time-point 
compared to the control levels (Fig. 2G, P=0.0090). There was a similar opening in all measured 
brain regions with an indication that the opening started around 12 hours (however not significant 
at this time-point) and reached a permeability peak at 24 hours after CIR. At the 48- and 72-hour 
time-points, the permeability of the BBB was returned to control levels.  
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Figure 2. The uptake of 14C-sucrose over the BBB was measured at different time-points after CIR 
to the young mouse brain (P21). The concentration of  14C-sucrose is presented in the entire brain 
(A), cortex (B), striatum/thalamus (C), brain stem (D), hippocampus (E), cerebellum (F) and in 
the CSF (G). Data shown as mean ± SEM. N=10Controls, 5-7CIR. P<0.01**, P<0.001***. Only 
statistical differences between the control and the CIR groups are shown in the histogram.  
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2.3 Neurofilament light protein serum concentration and correlation with blood-brain barrier 
permeability in mice 
Blood samples were collected from the mice pups during the acute phase following CIR (Fig. 3). 
Serum NFL concentrations were the highest at the first collection time point. Although a time-
dependent decline in NFL concentration following CIR was observed, the same trend was seen 
also in the control group that had only been sedated with tribromoethanol and not subjected to 
CIR. To investigate if the anesthetic drug influenced serum NFL levels, naïve control groups were 
consequently added to the experiment. These mice were brought to the irradiation facility at the 
hospital but were not subjected to anesthesia or irradiation. The results showed that only the 
sedated and CIR groups had higher concentrations of NFL in the blood, whilst naïve controls had 
unaltered low concentrations throughout the experiment (Fig. 3). Furthermore, only the CIR 
treated groups were significantly different over time compared to the naïve controls (P=0.003). At 
the 6-hour time-point the CIR group had a mean of 55.9 pg/ml whereas the anesthetized controls 
had a mean of 39.4 pg/ml and the naïve control mice a mean of 10.5 pg/ml. Importantly, NFL 
concentrations in blood did not correlate with the timing of BBB opening (Fig. 2).  
 
 
Figure 3. The levels of serum NFL were measured in mice at different time-points after CIR to the 
young mouse brain (P21). Data shown as mean ± SEM. N=6-11 per group. ** P<0.01, 
comparison between CIR and naïve controls over time.  
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2.4 Neurofilament light protein serum concentration and correlation with blood-
brain barrier permeability in humans 
To examine the relationship between serum NFL concentration and BBB permeability further, we 
measured CSF/serum albumin ratio (a BBB marker) and serum and CSF NFL concentrations in 
humans with varying degree of BBB impairment (Supplementary table 1, Fig. 4A-B). The groups 
were divided into those with an albumin ratio below 10 (normal range), a midrange group with a 
ratio of 10-20 and a high group with a ratio above 20 (severe BBB impairment). Although 
individuals with high CSF/serum albumin ratio often had higher concentrations of both CSF (Fig 
4A) and serum NFL (Figure 4B) concentrations compared with individuals with normal 
CSF/serum albumin ratio), there was no correlation of serum NFL concentration with CSF/serum 
albumin ratio (Figure 4C). In contrast, serum NFL concentrations correlated tightly with NFL 
concentrations in the CSF (Fig. 4D). 
 
10 
 
Figure 4. The levels of NFL were measured in CSF (A) and serum (B) from humans with different 
blood-brain barrier permeability. A CSF/serum albumin ratio <10 represents normal blood-brain 
barrier integrity (n=X), 10-20 medium permeability (n=X), >20 has a high permeability (n=X). 
Data is presented as median ± interquartile range (C). Patients with a CSF/serum albumin ratio 
lower than 30 and serum NFL lower than 400pg/ml are presented (six data points are missing, but 
presented in the supplementary table 1). No difference was seen between the groups and the level 
of serum NFL. (D) The levels of NFL in serum did reflect the NFL concentrations in CSF across 
groups with different degrees of blood-brain barrier permeability (r=0.6303, p<0.0001; all 
samples). To visualize the correlation only concentrations lower that 30.000pg/ml in CSF and 
lower than 300pg/ml are shown in the scatter plot (three data points are missing but presented in 
the supplementary table 1).  
 
Discussion 
This study aimed to investigate if it was possible to use serum NFL concentration as a biomarker 
for neuronal injury following CIR. The major findings were as follows: 1) there is an acute increase 
in serum NFL concentration in mice following both CIR and anesthesia, 2) serum levels of NFL 
in mice did not correlate with the opening of the BBB following CIR, 3) NFL concentration in 
serum reflects CSF NFL concentration independently of BBB permeability in patients with 
varying degrees of BBB impairment. Although the reasons for the increase in serum NFL after 
anesthesia needs further examination, these data suggest that the marker reflects CSF NFL 
concentration without being confounded by BBB permeability. 
 
 CIR 72h48h24h12h6h
DevDase
CCL2
ICAM-1
BBB
NFL
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Figure 5. Schematic overview of the process of CIR-induced injury response over time. 
The mice used in the current study were 3 weeks old (P21) and correlate developmentally with a 
3 year old child (Semple et al., 2013). Due to this, the brains are highly sensitive to CIR, which 
can be visualized in the cell death measurement that peaked at 6 hours post-CIR. This can be 
compared to the adult rodent brain where cell death was not measurable at this time after CIR 
(Blomstrand et al., 2014). Furthermore, we have previously shown that CIR induces a transient 
inflammatory response (Kalm et al., 2009). Chemokines are small peptides that are secreted during 
neuronal injury and play an important role in migration, leukocyte trafficking, and intracellular 
communication during neuroinflammation (Tambuyzer et al., 2009; Ubogu et al., 2006). CCL2 is 
the chemokine that shows the highest upregulation following CIR to the developing brain (Kalm 
et al., 2009). In this study, CCL2 showed a rapid upregulation and stayed elevated for 48 hours, 
hence 24 hours after the cell death levels had returned back to normal. Interestingly, the levels did 
not decrease until the integrity of the BBB had been restored. A large number of molecules could 
affect the permeability of the BBB and in this study the timeline correlates with the upregulation 
of both CCL2 and ICAM-1 (Overview, Fig. 5). CCL2 has been shown to disrupt the integrity of 
the BBB, and could therefore play an important role in disease progression (reviewed in Yao and 
Tsirka, 2014). Another step in the injury process following CIR, which could be of importance for 
the permeability of the BBB, is the recruitment of neutrophils. The level of ICAM-1 increased at 
the first time-point after CIR and stayed elevated during the duration of the experiment. ICAM-1 
is a key factor in trafficking neutrophils to sites of injury (Lyck and Enzmann, 2015). Slowing the 
neutrophils down in the blood circulation is a multistep procedure but is mediated by selectins on 
the endothelial surface (Zarbock et al., 2011). In this study, E-selectin followed the same 
expression pattern as ICAM-1, but there were no significant changes compared to baseline. There 
was however a significant difference between the 6-hour time-point and 24-hour time-point after 
CIR. The process of recruiting immune cells to the brain following CIR presumably affects the 
increased BBB permeability observed in the current study.  
In this study, a sensitive method with 14C-sucrose was used to investigate the BBB permeability 
after CIR to the developing mouse brain. It has been shown that irradiation of the brain increases 
permeability of cerebral vessels (evaluated by Evans blue staining) at 1 and 4 weeks after injury 
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in both young and adult mice (Sandor et al., 2014). Interestingly, Sandor et al. did investigate the 
permeability one day following CIR but could not detect any increased permeability. The 
difference between their results and the results observed in the current study could be due to the 
fact that Evans blue (EB) is a less sensitive method to measurement of BBB permeability compared 
to 14C-sucrose. Another possible explanation to this discrepancy is that EB binds to plasma proteins 
in blood and thus sucrose (342Da) is a much smaller molecule than the EB-plasma protein 
complexes. In this study, we wanted to investigate the acute phase following CIR to be able to 
correlate cell death, inflammation, BBB permeability and the optimal time-window to detect NFL 
in blood. Our data show that the BBB is affected 24 hours after a single dose of CIR to the young 
(P21) mouse brain. This knowledge could be of great importance, for example when combining 
drug therapies, such as chemotherapy, with radiotherapy toward the brain. Our data show that the 
BBB is opened with a time lag after CIR, which is of importance in the context of administering 
drugs simultaneously as CIR treatment. Since radiotherapy is given on weekdays (paused on 
weekends due to practical reasons), the effects of drug administered the first day of a week would 
in this aspect not be comparable if it instead was given the last day. Consequently, the amount of 
drug needed to reach the wanted concentration and effect in the brain the last day would 
presumably be lower compared to if the drug was given on the first day of treatment. Nevertheless, 
the BBB is highly affected by CIR and this could be explained by the injury and immune response.  
Neurofilaments are the major component of axonal cytoskeleton proteins, important for both 
morphologic integrity and conduction of nerve pulses along axons of neurons (Lee and Cleveland, 
1996). They consist of three subunits that differ in size where NFL is the smallest subunit. NFL is 
a well-examined biomarker in CSF for injury of large-caliber myelinated axons projecting into 
deeper brain layers and the spinal cord (Friede and Samorajski, 1970; Lee and Cleveland, 1996; 
Petzold, 2005). To monitor and predict late effects after CIR, a fluid biomarker that can reflect the 
injury process is of crucial importance. We have seen that NFL is highly elevated in CSF after 
prophylactic cranial radiotherapy in patients (Kalm et al., 2014). In addition, in this study we show 
that the levels of NFL in human CSF and blood correlate very well, without any influence by the 
integrity of the BBB. The NFL measurement in blood did peak at the 6-hour time-point in our 
mouse model of CIR and decreased successively afterwards. Another finding of importance was 
that anesthesia with tribromoethanol also showed a similar elevation of NFL in blood. Cell death 
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was however not detected in that group and could thereby not explain the results. By adding a 
naïve control group, we could exclude that stress was influencing the levels of NFL. This 
knowledge is hence important to consider when designing a mouse study and when selecting 
anesthesia. Nevertheless, tribromoethanol has an effect on neuronal integrity or function that can 
be measured in blood from mice. In a clinical study, peripheral injury (surgery and anesthesia) did 
not change the levels of NFL in CSF (Anckarsater et al., 2014), supporting that the effects of 
tribromoethanol presumably are mild. To continue, our findings suggest that NFL is a sensitive 
marker for neuronal injury. Others have also described NFL as a reliable and accessible biomarker 
to monitor neurodegenerative disease in mouse models (Bacioglu et al., 2016). In patients, serum 
NFL has been described as a potential biomarker for other neurological diseases, such as multiple 
sclerosis (Kuhle et al., 2016b), amyotrophic lateral sclerosis (Weydt et al., 2016) and progressive 
supranuclear palsy (Rojas et al., 2016). The levels of NFL in CSF and blood do correlate very well. 
With that in mind, Gisslén et al. have been able to detect NFL in blood of patients with HIV 
infection and found a strong correlation with NFL levels in CSF as well as a correlation with the 
severity of CNS infection (Gisslen et al., 2016). Further studies are needed to investigate if NFL 
can be used to predict the late effects following cranial radiotherapy.  
In conclusion, we examined how the BBB is affected during the acute time-window after CIR and 
if this affects the levels of serum NFL. CIR-induced cell death was followed by immune activation 
and increased permeability of the BBB. Despite our finding regarding tribromoethanol, the levels 
of NFL in serum did not correlate with a disturbed integrity of the BBB. These finding were also 
supported with human data showing that serum NFL was comparable to NFL in CSF, without any 
correlation with BBB permeability. Future studies are needed to verify how serum NFL is altered 
when CIR is given in a fractionating matter and under other anesthetic conditions. In summary, 
serum NFL has a good potential to act as a marker for neurotoxicity following cranial radiotherapy.  
4. Experimental procedures 
4.1 Animals 
Female C57BL/6 mice from Charles River Laboratories, Sulzfeld, Germany, were used in this 
study. The animals were ordered in litters containing 6 pups per litter. All animals were kept on a 
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12-hour light cycle with food and water provided ad libitum. All animal experiments were 
approved by the Gothenburg committee of the Swedish Animal Welfare Agency (2015-72).  
4.2 Cranial irradiation procedure 
A linear accelerator (Varian Clinac 1600 C-2 (250mu/min) and True Beam STX (600mu/min), 
Radiation Oncology Systems, LLC, San Diego, CA, USA) with 6 MV nominal photon energy was 
used for CIR. All animals were anesthetized on postnatal day (P) 21 with an intraperitoneal 
injection of 50 mg/kg of tribromoethanol (Sigma, Stockholm, Sweden) to immobilize the animals 
during the procedure. The animals were placed in a prone position on a polystyrene bed and the 
head was covered with a tissue equivalent material to obtain an even irradiation dose throughout 
the underlying tissue. Further, the whole brain was irradiated with 8 Gy, using a radiation field of 
2 x 2 cm and a source to skin distance of 99.5 cm. The variation of the absorbed dose was estimated 
to ±5%. An absorbed dose of 8 Gy is equivalent with 18 Gy delivered in 2-Gy fractions according 
to the linear quadratic formula and an alpha/beta ratio of 3 for late effects in the normal brain tissue 
(Fowler, 1989). The dose used for treatment of brain tumors in children, such as medulloblastoma, 
is higher, up to 55 Gy to the tumor bed. After the CIR procedure, the pups were placed on a warm 
bed (~36°C) to be able to maintain the body temperature of the animals. When the pups had 
recovered from the anesthesia, they were returned to their dams in their original cages until 
sacrificed. Control animals used in the experiments were anesthetized but not subjected to CIR. 
Naïve control animals were also used for the blood analysis of NFL. These mice were brought to 
the irradiation facility at the hospital but neither subjected to anesthesia nor CIR. 
4.3 Tissue preparation 
The brains were quickly removed after sacrifice, put in liquid nitrogen, and stored at -80°C. Brains 
were homogenized by sonication in phosphate-buffered saline (PBS) containing Triton X-100, 
ethylenediaminetetraacetic acid (EDTA, Sigma) and protease inhibitor cocktail (cOmplete, 
EDTA-free, ref 11873580001, Roche). After sonication, the samples were centrifuged and the 
cytosolic fractions were stored at -80°C. The total protein concentration was measured using a 
spectrophotometer (NanoDrop, ND-1000, Saveen Werner) before running the immunoassays. 
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4.4 Blood collection from mice 
Mice were anesthetized with a mixture of isoflurane and oxygen before blood collection. The chest 
was opened and blood was drawn from the heart with a 1 ml syringe (Omnifix®, BRAUN, 
Melsungen, Germany). Blood samples were immediately centrifuged for 5 minutes, serum was 
collected, transferred to a new tube and stored at -80°C. 
4.5 Fluorometric assay of caspase-3-like activity 
To measure CIR-induced caspase-dependent cell death, we used a caspase activity assay. Samples, 
20 µl, were added to a microplate and mixed with 80 µl extraction buffer (50 mM Tris-HCL, pH 
7.3; 100 mM NaCl; 5 mM EDTA; 1 mM EGTA; 0.2% 3-[(3-cholamidoprophylene) 
dimethylamonio]propane sulphonic acid; 1% protease inhibitor cocktail (cOmplete, EDTA-free, 
ref 11873580001, Roche); 1 mM phenylmethylsulfonylfluoride). After incubation for 15 minutes 
at room temperature, 100 µl peptide substrate, 25 µM Ac-Asp-Glu-Val-Asp-aminomethyl 
coumarine (Ac-DEVD-AMC; (#SAP3171v, Peptide Int.)) in assay buffer (50 mM Tris-HCl, pH 
7.3; 100 mM NaCl; 5 mM EDTA; 1 mM EGTA; 1 mM phenylmethylsulfonylfluoride, 10 mM 
dithiothreitol) was added to the samples. Cleavage of the substrate was measured at 37°C using 
Spectramax Gemini microplate fluorometer (Molecular Devices, Sunnyvale, CA) with an 
excitation wavelength of 380 nm and emission wavelength of 460 nm. The degradation was 
followed at 2-minute intervals for 1 hour, and V-max was calculated from the entire linear part of 
the curve. Standard curves with AMC in the appropriate buffer were used to express the data in 
picomoles of AMC (7-amino-4-methyl-coumarin) formed per minute and per milligram of protein. 
4.6 Enzyme-linked immunosorbent assay 
Enzyme-linked immunosorbent assays (ELISA) were used to investigate chemokine (C-C motif) 
ligand 2 (CCL2, MJE00, R&D Systems), Endothelial (E)-selectin (MES00, R&D Systems), 
intercellular adhesion molecule 1 (ICAM-1, MIC100, R&D Systems) expression after CIR. The 
analyses were performed according to the instructions of the manufacturers and the amount of the 
investigated proteins was measured using SpectraMax i3x (Molecular Devices, Sunnyvale, CA), 
with an excitation wavelength of 380 nm and emission wavelength of 460 nm. 
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4.7 Blood-brain and blood-CSF barrier permeability 
Measurements of BBB and blood-CSF barrier (BCB) permeability was performed similar to our 
previous studies (Ek et al., 2015) at 6-hours (n=5), 12-hours (n=5), 24-hours (n=7), 48-hours (n=5) 
and 72-hours (n=5) after CIR at P21 along with controls (n=10) which were mixed littermates from 
all time-points. 14C-sucrose (342Da; American Radiochemicals) was injected intraperitoneally 
(0.2 μCi/g body weight; 10 μl injection/g animal) and animals killed at 27 minutes after the 
injections with an i.p. injection of pentobarbital. Blood was collected from the heart and plasma 
was separated by centrifugation. CSF was collected from cisterna magna (4-6 μl) as previously 
described (Ek et al., 2001). The brain was dissected out and the hippocampus, cortex, 
striatum/thalamus and brain stem were collected in pre-weighed scintillation vials. Brain samples 
were digested with SOLVABLE™ (Perkin-Elmer). Scintillation fluid (Ultima-Gold, Perkin-
Elmer) was added to the vials and the radioactivity in all samples determined by liquid scintillation 
counting. Tissue radioactive concentrations were corrected for residual blood volume space to 
obtain true tissue concentrations as previously described (Bolouri et al., 2014). Brain/blood and 
CSF/blood concentration ratios were calculated as an index of BBB and BCB permeability.  
4.8 Clinical samples 
Paired lumbar CSF and serum samples from clinical laboratory routine were selected to represent 
different degrees of BBB dysfunction. The selection was based on the CSF/serum albumin ratio, 
the best-established clinical biomarker for blood-brain barrier function (Tibbling et al., 1977). 
Following selection, the samples were terminally de-identified and analyzed for CSF and serum 
NFL as described below. Biochemical data are given in Supplementary table 1. The age and gender 
distribution was comparable between the groups. All procedures were approved by the Regional 
Ethics Committee at the University of Gothenburg.   
4.9 CSF/serum albumin ratio (humans) 
Albumin levels in serum and CSF were measured by immunonephelometry on a Beckman Immage 
Immunochemistry system (Beckman Instruments, Beckman Coulter, Brea, CA). The albumin ratio 
was calculated as CSF albumin (mg/l)/serum albumin (g/l) and was used as a measure of the BBB 
function. 
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4.10 CSF NFL (humans) 
CSF NFL concentration was measured using the NF-Light ELISA, as described by the kit 
manufacturer (UmanDiagnostics, Umeå, Sweden).  
 
4.11 Serum NFL (mice and humans) 
The amino acid sequence of NFL is 100% conserved between rodents and humans. Serum sample 
NFL concentration was determined using an in-house NFL assay on the Single molecule array 
(Simoa) platform, which has been described in detail previously (Kuhle et al., 2016a). Briefly, 
paramagnetic carboxylated beads (Quanterix Corp, Boston, MA, USA) were coated with a mouse 
anti-neurofilament light antibody (UD1, UmanDiagnostics, Umeå, Sweden) and incubated 35 
minutes with sample and a biotinylated mouse anti–neurofilament light antibody (UD2, 
UmanDiagnostics) in a Simoa HD-1 instrument (Quanterix). The bead-conjugated 
immunocomplex was thoroughly washed before incubation with streptavidin-conjugated β-
galactosidase (Quanterix). After additional washes, resorufin β-D-galactopyranoside (Quanterix) 
was added and the immunocomplex was applied to a multiwell array designed to enable imaging 
of every single bead. The average number of enzymes per bead (AEB) of samples was interpolated 
onto the calibrator curve constructed by AEB measurements on bovine NFL (UmanDiagnostics) 
serially diluted in assay diluent. Samples were analyzed using one batch of reagents and animal 
treatment information was blinded to the one performing the analysis. The average repeatability 
of the assay was assessed by measurements of quality control samples and the coefficient of 
variation was 4.2% for a sample with a mean NFL concentration of 20.1 pg/ml, and 6.2% for a 
sample with a mean NFL concentration of 50.0 pg/ml. Similarly, the inter-assay coefficient of 
variation was 5.0% and 6.8% for each quality control sample. The limit of detection (LOD), 
determined as the mean blank signal + 3 SD for the Simoa NFL assay was 0.3 pg/ml and the lower 
limit of quantification (LLOQ) determined as the mean blank signal + 10SD was 2.7 pg/ml when 
compensated for a four-fold sample dilution. 
4.12 Statistics 
For statistical analysis of DevDase, CCL2, ICAM-1, E-selectin and NFL (humans), one-way 
ANOVA with Bonferroni post hoc testing was used. NFL for the mice was analyzed with a two-
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way ANOVA with time and treatment as main effects. All analyses on mice data were performed 
using SPSS 23.0 (SPSS, Chicago, IL, USA) and statistical significance was considered if P<0.05. 
The clinical correlation analysis between serum and CSF NFL was performed using Pearson r 
(GraphPad Prism 7.02). Comparisons between the a CSF/serum albumin groups and levels of NFL 
was performed using one-way ANOVA with Bonferroni post hoc using SPSS 23.0 (SPSS, 
Chicago, IL, USA) 
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